124 related articles for article (PubMed ID: 3235892)
1. [The efficacy of combined use of 1 alpha-hydroxyvitamin D3 with calcium supplements in the treatment of osteoporosis].
Yoshikawa S; Ohno A; Moro K; Matsumoto M; Nemoto H; Seki H; Kaneko N; Hosokawa O; Ishijima H
Nihon Seikeigeka Gakkai Zasshi; 1988 Aug; 62(8):723-32. PubMed ID: 3235892
[TBL] [Abstract][Full Text] [Related]
2. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
3. Interim report on treatment of osteoporotic patients with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):232-40. PubMed ID: 709936
[TBL] [Abstract][Full Text] [Related]
4. [Effects of long-term administration of alfacalcidol on bone mass and bone metabolism in patients with primary osteoporosis--comparison with calcium preparations].
Nakatsuka K; Inaba M; Aratani H; Iba K; Sato T; Koike T; Miki T; Nishizawa Y; Morii H
Nihon Ronen Igakkai Zasshi; 1997 Jul; 34(7):569-76. PubMed ID: 9388377
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of postmenopausal osteoporosis with 1-alpha(OH)D3].
Petkakov M; Popović V; Milić D; Damjanović S; Manojlović D; Mićić J
Srp Arh Celok Lek; 1995; 123(7-8):171-3. PubMed ID: 17974421
[TBL] [Abstract][Full Text] [Related]
6. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.
Orimo H; Shiraki M; Hayashi T; Nakamura T
Bone Miner; 1987 Oct; 3(1):47-52. PubMed ID: 3505192
[TBL] [Abstract][Full Text] [Related]
7. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.
Geusens P; Dequeker J
Bone Miner; 1986 Sep; 1(4):347-57. PubMed ID: 3333018
[TBL] [Abstract][Full Text] [Related]
9. Preventive treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Evaluation of bone histomorphometry in osteoporotics and age matched controls.
Lindholm TS; Nilsson OS; Widhe T; Elmsted E; Eriksson S
Acta Vitaminol Enzymol; 1982; 4(1-2):179-84. PubMed ID: 7124565
[No Abstract] [Full Text] [Related]
10. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
11. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S; Lindholm TC
Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
[TBL] [Abstract][Full Text] [Related]
12. Effect of 1 alpha-hydroxyvitamin D3 on osteoporosis induced by immobilization combined with ovariectomy in rats.
Okumura H; Yamamuro T; Kasai R; Hayashi T; Tada K; Nishii Y
Bone; 1987; 8(6):351-5. PubMed ID: 3449110
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. [Effect of 1-alpha oxyvitamin D3 on bone tissue in systemic osteoporosis].
Rodionova SS; Zatsepin ST; Shvets VN
Ortop Travmatol Protez; 1989 Feb; (2):37-40. PubMed ID: 2726218
[TBL] [Abstract][Full Text] [Related]
15. [Vitamin D and calcium for the treatment of osteoporosis].
Inoue D
Nihon Rinsho; 2009 May; 67(5):967-74. PubMed ID: 19432118
[TBL] [Abstract][Full Text] [Related]
16. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.
Hillman LS; Cassidy JT; Chanetsa F; Hewett JE; Higgins BJ; Robertson JD
Arthritis Rheum; 2008 Oct; 58(10):3255-63. PubMed ID: 18821668
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR
Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489
[TBL] [Abstract][Full Text] [Related]
18. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
Ringe JD; Faber H; Fahramand P; Schacht E
J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
[TBL] [Abstract][Full Text] [Related]
19. 1-Alpha-OH-cholecalciferol (1-alpha-OH-D3) and optimal calcium intake in calcium deficiency osteoporosis mediated by parathyroid activity morphologic and biochemical changes in adult male rats.
Lindholm TS; Nilsson OS; Lindholm TC
Acta Vitaminol Enzymol; 1985; 7(1-2):39-47. PubMed ID: 4036758
[TBL] [Abstract][Full Text] [Related]
20. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
